Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Faruk

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Medical Hypotheses|March 17, 2007
Message-adjusted network (MAN) hypothesis in gastro-entero-pancreatic (GEP) endocrine systemN Faruk Aykan
American Journal of Clinical Oncology|April 25, 2001
Measurement of serum CA 19-9 may be more valuable than CEA in prediction of recurrence in patients with gastric cancerF Tas, N Faruk Aykan, A Aydiner, et al.
The Tohoku Journal of Experimental Medicine|April 23, 2003
Colorectal cancer in young patients: characteristics and outcomeSüleyman Alici, N Faruk Aykan, Burak Sakar, et al.
Journal of Gastrointestinal Oncology|July 20, 2012
A pilot study evaluating the safety and toxicity of epirubicin, cisplatin, and UFT (ECU regimen) in advanced gastric carcinomaSezer Saglam, N Faruk Aykan, Burak Sakar, et al.
American Journal of Clinical Oncology|December 15, 2004
Prognostic features and survival of inoperable hepatocellular carcinoma in Turkish patients with cirrhosisBurak Sakar, Zeki Ustuner, Hakan Karagol, et al.
Medical Oncology (Northwood, London, England)|August 8, 2013
Effect of increased body mass index (BMI) on time to tumour progression (TTP) in unresectable metastatic colorectal cancer (mCRC) patients treated with bevacizumab-based therapyN Faruk Aykan, Ibrahim Yildiz, Fatma Sen, et al.
American Journal of Clinical Oncology|December 13, 2002
Adjuvant intraperitoneal chemotherapy with cisplatinum, mitoxantrone, 5-fluorouracil, and calcium folinate in patients with gastric cancer: a phase II studyErkan Topuz, Mert Basaran, Pinar Saip, et al.
Heliyon|November 16, 2020
Multimedia tools in the teaching and learning processes: A systematic reviewM D Abdulrahaman, N Faruk, A A Oloyede, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Medical Hypotheses|March 17, 2007
Message-adjusted network (MAN) hypothesis in gastro-entero-pancreatic (GEP) endocrine systemN Faruk Aykan
American Journal of Clinical Oncology|April 25, 2001
Measurement of serum CA 19-9 may be more valuable than CEA in prediction of recurrence in patients with gastric cancerF Tas, N Faruk Aykan, A Aydiner, et al.
The Tohoku Journal of Experimental Medicine|April 23, 2003
Colorectal cancer in young patients: characteristics and outcomeSüleyman Alici, N Faruk Aykan, Burak Sakar, et al.
Journal of Gastrointestinal Oncology|July 20, 2012
A pilot study evaluating the safety and toxicity of epirubicin, cisplatin, and UFT (ECU regimen) in advanced gastric carcinomaSezer Saglam, N Faruk Aykan, Burak Sakar, et al.
American Journal of Clinical Oncology|December 15, 2004
Prognostic features and survival of inoperable hepatocellular carcinoma in Turkish patients with cirrhosisBurak Sakar, Zeki Ustuner, Hakan Karagol, et al.
Medical Oncology (Northwood, London, England)|August 8, 2013
Effect of increased body mass index (BMI) on time to tumour progression (TTP) in unresectable metastatic colorectal cancer (mCRC) patients treated with bevacizumab-based therapyN Faruk Aykan, Ibrahim Yildiz, Fatma Sen, et al.
American Journal of Clinical Oncology|December 13, 2002
Adjuvant intraperitoneal chemotherapy with cisplatinum, mitoxantrone, 5-fluorouracil, and calcium folinate in patients with gastric cancer: a phase II studyErkan Topuz, Mert Basaran, Pinar Saip, et al.
Heliyon|November 16, 2020
Multimedia tools in the teaching and learning processes: A systematic reviewM D Abdulrahaman, N Faruk, A A Oloyede, et al.
Pageof 1